Company Filing History:
Years Active: 2018
Title: Jin Won Yang - Innovator in Pharmaceutical Composition
Introduction
Jin Won Yang is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of liver diseases. His innovative work focuses on developing compositions that can effectively prevent or treat liver fibrosis.
Latest Patents
Jin Won Yang holds a patent for a pharmaceutical composition aimed at preventing or treating cirrhosis of the liver. The patent describes a composition that includes a G protein-coupled receptor 119 (GPR119) ligand as an active ingredient. This composition has been shown to significantly inhibit the expression of collagen I, transforming growth factor β (TGFβ), and α-smooth muscle actin (α-SMA). As a result, it effectively inhibits hepatic stellate cell (HSC) activation and proliferation, making it a promising candidate for the improvement, prevention, inhibition, or treatment of liver fibrosis.
Career Highlights
Jin Won Yang is associated with Pharmedix Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on liver health and treatment options.
Collaborations
Jin Won Yang collaborates with esteemed colleagues, including Keon Wook Kang and Kyeong Seok Lee, who contribute to his research endeavors.
Conclusion
Jin Won Yang's innovative contributions to pharmaceutical compositions highlight his commitment to improving liver disease treatments. His work exemplifies the importance of research in developing effective medical solutions.